Sudden Cardiac Death in Schizophrenia: A Review

Area of Science:

• Cardiology
• Psychiatry
• Genetics

Background:

• Cardiovascular disease causes nearly 50% of deaths in schizophrenia patients, with sudden cardiac death occurring at four times the general population rate.
• While ischemic heart disease is a major factor, 10% of sudden deaths in this group are unexplained, potentially due to cardiac arrhythmias.

Purpose of the Study:

• To review factors contributing to increased cardiovascular mortality in schizophrenia.
• To highlight the role of antipsychotic drugs, Brugada pattern, autonomic nervous system, and genetic factors in sudden cardiac death risk.

Main Methods:

• Literature review of studies on cardiovascular disease in schizophrenia.
• Discussion of drug effects on ion channels, genetic polymorphisms, and autonomic function.
• Emphasis on risk factor control and noninvasive risk assessment.

Main Results:

• Antipsychotic medications can affect ion channel function, potentially increasing arrhythmia risk.
• Schizophrenia patients show a higher incidence of Brugada pattern, a risk factor for sudden cardiac death.
• The neuregulin 1 (NRG1) gene polymorphism rs10503929, specifically the minor allele C, is associated with increased sudden cardiac death risk.

Conclusions:

• Increased cardiovascular mortality in schizophrenia is multifactorial, involving drug effects, genetic predispositions, and autonomic dysfunction.
• Aggressive management of traditional cardiovascular risk factors and identification of high-risk individuals are essential.
• Further research into genetic and electrophysiological markers may improve risk stratification and prevention strategies.